JPRN-UMIN000014737已完成未知
The effects of denosumab compared with oral bisphosphonates (BP) in patients with RA complicated with osteoporosis on the progression of structural damage, BMD and disease activity. - Two Birds trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 286
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Use of a biologics agent for RA within 8 weeks before trial (2) Use of JAK inhibitor (3) Gulcocorticoid dose >10mg/day (prednisone or equivalent) (4) Patients whom the doctor judged unsuitable for participation from medical reason.
研究者
相似试验
招募中
不适用
Comparison of therapeutic effects of denosumab and romosozumab using Propensity Score Matching in postmenopausal osteoporosis patientsPrimary osteoprosisosteoprosisD0 1 0 0 2 4JPRN-jRCT1041200090Kobayakawa Tomonori150
已完成
3 期
A randomised, double-blind, placebo controlled trial to examine the effects of total oestradiol depletion on bone microstructure and the efficacy of denosumab in preventing microstructural bone decay in premenopausal women with early breast cancerMetabolic and Endocrine - Other endocrine disordersCancer - BreastMusculoskeletal - Osteoporosisbreast cancerpremenopausal osteoporosisACTRN12616001051437Professor Mathis Grossmann74
已完成
不适用
The effect of denosumab for the treatment of osteoporosis in hemodialysis patientsOsteoporosisJPRN-UMIN000014458Saiseikai Kumamoto Hospital40
招募中
4 期
Comparison of usefulness between denosumab and alendronate after teriparatide therapy in patients with glucocorticoid-induced osteoporosis (GIOP)glucocorticoid-induced osteoporosis (GIOP)JPRN-UMIN000014570Saitama Medical University40
招募中
不适用
The effects of denosumab compared with alendronate on glucocorticoid-induced osteoporosis in patients with malignant lymphomaglucocorticoid-induced osteoporosis in patients with malignant lymphomaJPRN-UMIN000038881Toyama University Hospital Department of Hematology100